To replay the call, visit and you can download the accompanying slides here.
On Wednesday 11 November 13:00 GMT (08:00 ET), 4D pharma CEO Duncan Peyton and CSO Alex Stevenson are joined by Dr Mark P Lythgoe, Academic Clinical Fellow in Medical Oncology and Pharmacist at Imperial College London, and Dr Shubham Pant, Associate Professor Department of Investigational Cancer Therapeutics and Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center, to discuss immuno-oncology LBP MRx0518 monotherapy and checkpoint inhibitor combination data published at SITC 2020. KOL Event: MRx0518 SITC 2020 data, 11 November 2020 View RNS announcements Subscribe to RNS email alertsįor any enquiries please contact Events & Presentations Interim results for the period ended 30 June 2014 Interim results for the period ended 30 June 2015Īnnual Report for the year ended 31 December 2014 Interim results for the period ended 30 June 2016Īnnual report for the year ended 31 December 2015 Interim results for the period ended 30 June 2017Īnnual report for the year ended 31 December 2016 Interim results for the period ended 30 June 2018Īnnual report for the year ended 31 December 2017 Annual report for the year ended 31 December 2018
0 kommentar(er)
